RFS
IONS icon

Rockefeller Financial Services’s Ionis Pharmaceuticals IONS Stock Holding History

Rockefeller Financial Services’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,879
Closed -$114K – 476
2016
Q2 		$114K Buy
+4,879
New +$157K ﹤0.01% 345
2015
Q3 		– Sell
-2,587
Closed -$149K – 518
2015
Q2 		$149K Hold
2,587
– – ﹤0.01% 340
2015
Q1 		$165K Hold
2,587
– – ﹤0.01% 336
2014
Q4 		$160K Hold
2,587
– – ﹤0.01% 320
2014
Q3 		$100K Sell
2,587
-7,614
-75% -$270K ﹤0.01% 363
2014
Q2 		$351K Buy
10,201
+2,769
+37% +$87.2K 0.01% 289
2014
Q1 		$321K Sell
7,432
-4,191
-36% -$203K 0.01% 299
2013
Q4 		$463K Sell
11,623
-2,570
-18% -$91.6K 0.01% 276
2013
Q3 		$533K Buy
14,193
+8,089
+133% +$242K 0.01% 258
2013
Q2 		$164K Buy
+6,104
New +$130K ﹤0.01% 347

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Rockefeller Financial Services's IONS Position: Q3 2016 in Review

Rockefeller Financial Services sold out of Ionis Pharmaceuticals (IONS) in Q3 2016, closing a stake of 4,879 shares — an estimated $114K sold.

Rockefeller Financial Services first reported a position in IONS in Q2 2013 and held it in 10 quarters. The position peaked at $533K in Q3 2013. 281 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

  • Rockefeller Financial Services reported no remaining Ionis Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Rockefeller Financial Services sold 4,879 Ionis Pharmaceuticals shares in Q3 2016, an estimated $114K.
  • Rockefeller Financial Services first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • Rockefeller Financial Services's Ionis Pharmaceuticals position peaked at $533K in Q3 2013.
  • 281 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on Rockefeller Financial Services's 13F filing for Q3 2016, filed 28 Oct 2016.